Swenerton KD - Search Results

1

Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies.

Lê LH, Swenerton KD, Elit L, Provencher DM, Stuart GC, LE T, Lee U, Rodgers A, Pond GR, Hu H, Oza AM. Lê LH, et al. Among authors: swenerton kd. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):799-806. doi: 10.1111/j.1525-1438.2005.00139.x. Int J Gynecol Cancer. 2005. PMID: 16174227 Free article. Clinical Trial.

2

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).

Oza AM, Elit L, Swenerton K, Faught W, Ghatage P, Carey M, McIntosh L, Dorr A, Holmlund JT, Eisenhauer E; NCIC Clinical Trials Group Study (NCIC IND.116). Oza AM, et al. Gynecol Oncol. 2003 Apr;89(1):129-33. doi: 10.1016/s0090-8258(02)00144-0. Gynecol Oncol. 2003. PMID: 12694666 Clinical Trial.

3

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.

Mackay HJ, Tinker A, Winquist E, Thomas G, Swenerton K, Oza A, Sederias J, Ivy P, Eisenhauer EA. Mackay HJ, et al. Gynecol Oncol. 2010 Feb;116(2):163-7. doi: 10.1016/j.ygyno.2009.08.012. Epub 2009 Sep 8. Gynecol Oncol. 2010. PMID: 19740535 Clinical Trial.

4

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

Swenerton K, Jeffrey J, Stuart G, Roy M, Krepart G, Carmichael J, Drouin P, Stanimir R, O'Connell G, MacLean G, et al. Swenerton K, et al. J Clin Oncol. 1992 May;10(5):718-26. doi: 10.1200/JCO.1992.10.5.718. J Clin Oncol. 1992. PMID: 1569444 Clinical Trial.

5

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.

Hoskins PJ, Le N, Ellard S, Lee U, Martin LA, Swenerton KD, Tinker AV; British Columbia Cancer Agency. Hoskins PJ, et al. Among authors: swenerton kd. Gynecol Oncol. 2008 Jan;108(1):58-62. doi: 10.1016/j.ygyno.2007.08.084. Epub 2007 Oct 23. Gynecol Oncol. 2008. PMID: 17935761

6

A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.

Swenerton K, Hoskins P, Stuart G, Batist G, Pike J, Onetto N, Fisher B, Eisenhauer E. Swenerton K, et al. Ann Oncol. 1996 Dec;7(10):1077-9. doi: 10.1093/oxfordjournals.annonc.a010502. Ann Oncol. 1996. PMID: 9037368 Free article. Clinical Trial.

7

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

Hirte H, Oza A, Swenerton K, Ellard SL, Grimshaw R, Fisher B, Tsao M, Seymour L. Hirte H, et al. Gynecol Oncol. 2010 Sep;118(3):308-12. doi: 10.1016/j.ygyno.2010.05.005. Epub 2010 Jun 19. Gynecol Oncol. 2010. PMID: 20646751 Clinical Trial.

8

Better therapeutic trials in ovarian cancer.

Bookman MA, Gilks CB, Kohn EC, Kaplan KO, Huntsman D, Aghajanian C, Birrer MJ, Ledermann JA, Oza AM, Swenerton KD. Bookman MA, et al. Among authors: swenerton kd. J Natl Cancer Inst. 2014 Apr;106(4):dju029. doi: 10.1093/jnci/dju029. Epub 2014 Mar 13. J Natl Cancer Inst. 2014. PMID: 24627272 Free PMC article. Review.

9

RETIRED: Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint Review and Committee Opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada.

McNaught J, Reid RL; SOGC/GOC JOINT AD HOC COMMITTEE ON BREAST CANCER. McNaught J, et al. J Obstet Gynaecol Can. 2006 Jul;28(7):616-626. doi: 10.1016/S1701-2163(16)32195-8. J Obstet Gynaecol Can. 2006. PMID: 16924781 English, French. No abstract available.

10

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, Oza A. Gelmon KA, et al. Lancet Oncol. 2011 Sep;12(9):852-61. doi: 10.1016/S1470-2045(11)70214-5. Epub 2011 Aug 19. Lancet Oncol. 2011. PMID: 21862407 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters